Imatinib for progressive and recurrent aggressive fibromatosis (desmoid tumors): an FNCLCC/French Sarcoma Group phase II trial with a long-term follow-up

Nicolas Penel, Axel Le Cesne, B. Bui, +12

Annals of Oncology

MedicineFnclcc/french Sarcoma GroupPathologyOncologyRadiation Oncology +3

A phase II study of vinflunine in bladder cancer patients progressing after first-line platinum-containing regimen

Stéphane Culine, Christine Théodore, Maria De Santis, +7

British Journal of Cancer

Neo/adjuvant chemotherapy does not improve outcome in resected primary synovial sarcoma: a study of the French Sarcoma Group

Antoîne Italiano, Nicolas Penel, Y Robin, +12

Annals of Oncology

Surgical OncologyMedicineNeo/adjuvant ChemotherapyOncologyRadiation Oncology +1

Chemotherapy in patients with desmoid tumors: a study from the French Sarcoma Group (FSG)

Delphine Garbay, Axel Le Cesne, Nicolas Penel, +12

Annals of Oncology

Malignant DiseaseMedicinePathologyFrench Sarcoma GroupCancer Treatment +5

Advanced well-differentiated/dedifferentiated liposarcomas: role of chemotherapy and survival

Antoîne Italiano, Maud Toulmonde, Angela Cioffi, +14

Annals of Oncology

Advanced Well-differentiated/dedifferentiated LiposarcomasMedicineSurgical PathologyPathologyCancer Treatment +2

Phase II clinical trial of neoadjuvant trabectedin in patients with advanced localized myxoid liposarcoma

Alessandro Gronchi, B. Bui, Sylvie Bonvalot, +13

Annals of Oncology

Effect of adjuvant chemotherapy on survival in FNCLCC grade 3 soft tissue sarcomas: a multivariate analysis of the French Sarcoma Group Database

Antoîne Italiano, Fleur Delva, Simone Mathoulin‐Pélissier, +8

Annals of Oncology

Surgical OncologyMedicineCancer ManagementAdjuvant ChemotherapyPathology +6

Metastatic angiosarcomas: doxorubicin-based regimens, weekly paclitaxel and metastasectomy significantly improve the outcome

Nicolas Penel, Antoîne Italiano, Isabelle Ray‐Coquard, +12

Annals of Oncology

Surgical OncologyMedicinePathologyWeekly PaclitaxelSurgery +5

Influence of imatinib interruption and rechallenge on the residual disease in patients with advanced GIST: results of the BFR14 prospective French Sarcoma Group randomised, phase III trial

Anna Patrikidou, Sylvie Chabaud, Isabelle Ray‐Coquard, +11

Annals of Oncology

Residual DiseaseSurgical OncologyMedicineMetronomic TherapyPhase Iii Trial +6

Prospective evaluation of quality of surgery in soft tissue sarcoma

E. Stoeckle, H. Gardet, J-M Coindre, +6

European Journal of Surgical Oncology

Surgical OncologySoft Tissue SurgerySurgical PathologyProspective EvaluationSurgery +2